Showing 1 - 10 results of 10 for search 'Neena VERMA', query time: 0.04s
Refine Results
-
1
Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India. by Sakib Burza, Prabhat K Sinha, Raman Mahajan, María Angeles Lima, Gaurab Mitra, Neena Verma, Manica Balasegaram, Pradeep Das
Published 2014-01-01
Article -
2
Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India. by Sakib Burza, Prabhat Kumar Sinha, Raman Mahajan, Marta González Sanz, María Angeles Lima, Gaurab Mitra, Neena Verma, Pradeep Das
Published 2014-01-01
Article -
3
A Community Based Cohort Study on Usefulness of Leishmanin Skin Test in Detection of Immunoreactivity Against Leishmania donovani Infection in an Endemic Area of Kala-Azar, Bihar,... by Neena Verma, Sanjiva Bimal, Kumar Gupta Anil, Chandra Lal, Alok Ranjan, Rakesh Verma, K Pandey, Vidya Nand Rabidas, Shantanu Kar, P Das
Published 2019-12-01
Article -
4
To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL). by Vidya Nand Rabi Das, Niyamat Ali Siddiqui, Biplab Pal, Chandra Shekhar Lal, Neena Verma, Ashish Kumar, Rakesh Bihari Verma, Dhirendra Kumar, Pradeep Das, Krishna Pandey
Published 2017-01-01
Article -
5
Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study. by Sushmita Das, Rakesh Mandal, Vidya Nand Rabidas, Neena Verma, Krishna Pandey, Ashok Kumar Ghosh, Sreekant Kesari, Ashish Kumar, Bidyut Purkait, Chandra Sekhar Lal, Pradeep Das
Published 2016-10-01
Article -
6
Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study. by Shyam Sundar, Krishna Pandey, Chandreshwar Prasad Thakur, Tara Kant Jha, Vidya Nand Ravi Das, Neena Verma, Chandra Shekhar Lal, Deepak Verma, Shahnawaz Alam, Pradeep Das
Published 2014-09-01
Article -
7
Advanced case of PKDL due to delayed treatment: A rare case report. by Roshan Kamal Topno, Vidya Nand Rabi Das, Maneesh Kumar, Major Madhukar, Krishna Pandey, Neena Verma, Kanhaiya Agrawal, Chandra Shekhar Lal, Niyamat Ali Siddiqui, Sanjiva Bimal, Pradeep Das
Published 2020-03-01
Article -
8
Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome). by Sakib Burza, Raman Mahajan, Prabhat K Sinha, Johan van Griensven, Krishna Pandey, María Angeles Lima, Marta Gonzalez Sanz, Temmy Sunyoto, Sunil Kumar, Gaurab Mitra, Ranjeet Kumar, Neena Verma, Pradeep Das
Published 2014-08-01
Article -
9
Early diagnostic marker for the conversion of asymptomatic to symptomatic visceral leishmaniasis by Roshan Kamal Topno, Rajeev Kumar, Krishna Pandey, Manas Ranjan Dikhit, Major Madhukar, Maneesh Kumar, Sanjiva Bimal, Niyamat Ali Siddiqui, Vidyanand Ravi Das, Kanhaiya Agrawal, Neena Verma, Chandra Shekhar Lal, Pradeep Das
Published 2019-07-01
Article -
10
Identification of Clinical Immunological Determinants in Asymptomatic VL and Post Kala-azar Dermal Leishmaniasis Patients by Ashish Kumar SINGH, Vidya Nand Rabi DAS, Ajay AMIT, Manas R DIKHIT, Vijaya MAHANTESH, Akhilesh KUMAR, Raj Kishore PANDEY, Shyam NARYAN, Bipin K SINGH, Krishna PANDEY, Neena VERMA, Pradeep DAS, Sanjiva BIMAL
Published 2018-12-01
Article